Affordable Access

Publisher Website

Treatment outcomes after splenectomy with gastric devascularization or balloon-occluded retrograde transvenous obliteration for gastric varices: a propensity score-weighted analysis from a single institution

  • Oshita, Ko1
  • Ohira, Masahiro1, 2
  • Honmyo, Naruhiko1
  • Kobayashi, Tsuyoshi1
  • Murakami, Eisuke1, 1
  • Aikata, Hiroshi1, 1
  • Baba, Yasutaka1
  • Kawano, Reo2
  • Awai, Kazuo1
  • Chayama, Kazuaki1, 1
  • Ohdan, Hideki1
  • 1 Hiroshima University,
  • 2 Hiroshima University Hospital,
Published Article
Journal of Gastroenterology
Springer Singapore
Publication Date
Jun 12, 2020
DOI: 10.1007/s00535-020-01693-9
PMID: 32533300
PMCID: PMC7289714
PubMed Central


Background Although balloon-occluded retrograde transvenous obliteration (BRTO) is often selected to treat gastric varices caused by portal hypertension, data comparing BRTO and splenectomy with gastric devascularization (Sp + Dev) are limited. Methods From January 2009 to February 2018, 100 patients with gastric varices caused by portal hypertension who underwent Sp + Dev ( n = 45) or BRTO ( n = 55) were included. Overall survival (OS) and the rebleeding rate were calculated using the inverse probability of a treatment weighting-adjusted log-rank test. Independent risk factors were identified by Cox regression analysis. Changes in liver function and adverse events after the procedures were analyzed. Results Patients in the Sp + Dev group tended to have lower platelet counts than those in the BRTO group, but liver function did not differ between these groups. The 5-year OS rates for the Sp + Dev and BRTO groups were 73.4 and 50.0% ( p = 0.005), respectively. There were no significant differences in rebleeding rates between the two groups. Multivariate analysis showed that serum albumin level ≤3.6 g/dL, prothrombin time% activity (PT%) ≤80%, and serum creatinine level ≥0.84 mg/dL were poor prognostic factors. Although the Sp + Dev group had more short-term complications after procedures, Sp + Dev tended to be more effective in improving liver function than BRTO. Conclusions Sp + Dev showed better OS and improvement of liver function compared with BRTO for the treatment of gastric varices caused by portal hypertension. Electronic supplementary material The online version of this article (10.1007/s00535-020-01693-9) contains supplementary material, which is available to authorized users.

Report this publication


Seen <100 times